Author(s): Silverman SL
Abstract Share this page
Abstract Bisphosphonates are the gold standard of treatment of postmenopausal osteoporosis, male osteoporosis, and steroid-induced osteoporosis. They have potential use in multiple musculoskeletal conditions other than osteoporosis and have also been shown to treat Paget's disease of the bone and osteogenesis imperfecta. Bisphophonates may have potential use in periprosthetic bone loss, osteonecrosis of the hip, fibrous dysplasia, and calcinosis in juvenile dermatomyositis. © 2010 New York Academy of Sciences.
This article was published in Ann N Y Acad Sci
and referenced in Journal of Molecular Biomarkers & Diagnosis